Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Vet Immunol Immunopathol. 2014 May 2;160(0):167–176. doi: 10.1016/j.vetimm.2014.04.009

Fig. 2.

Fig. 2

MANS peptide inhibits equine neutrophil migration toward multiple chemoattractants. MANS peptide demonstrated a dose dependent inhibition (A) of LTB4 stimulated equine neutrophil migration in vitro. (B) Compared to RNS 50 μM treatment, MANS 50 μM significantly inhibited both chemoattractant stimulated (gradient and non-gradient) and non-stimulated (VC) migration. Data presented as mean ± SEM, *p < 0.05 MANS vs. RNS, n = 6.